Nabi Biopharmaceuticals (NABI) Reports Q3 Loss of $0.12

November 8, 2012 5:33 PM EST
Get Alerts NABI Hot Sheet
Trade NABI Now!
Join SI Premium – FREE
Nabi Biopharmaceuticals (NASDAQ: NABI) reported Q3 EPS of ($0.12), versus ($0.07) reported last year. Revenue for the quarter came in at $632 thousand, versus $1.1 million reported last year.

For earnings history and earnings-related data on Nabi Biopharmaceuticals (NABI) click here.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories


Related Entities


Add Your Comment